Latest filing published 17 Dec 2025 for National Research CORP, €160k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Helen Hrdy: trading record in brief
This profile gathers the share dealings of Helen Hrdy in NRC Health, where the filings describe the role as senior executive. Between 28 December 2021 and 15 December 2025, the trades on record add up to 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 17 December 2025, reports a share grant of €169k in NRC Health. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Helen Hrdy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,346 shares@ US$15.2350.5% of flowCommon StockSEC:0001008886-25-000321:0
- 100,000 shares0Common StockSEC:0001008886-25-000068:0
- 13,520 shares@ US$13.1749.5% of flowCommon StockSEC:0001567619-21-022684:0
3 of 3 declarations